BioGaia

Major Shareholding Notification • Oct 31, 2016

Press Release 31 October 2016

Disclosure notice in BioGaia

Sebastian Jahreskog, BioGaia's second largest shareholder, has announced that he has sold his shares in BioGaia to an endowment insurance. With this, he flagged a sale. The transaction only means a modified form of ownership and Sebastian Jahreskog intends to retain his holdings of BioGaia.

For additional information please contact Axel Sjöblad, Managing Director, telephone: +46 8 555 293 00

Latest press releases from BioGaia

2016-10-25	BioGaia AB Interim Management statement 1 January – 30 September 2016
2016-10-14	BioGaia's probiotics to be launched in Kenya, Nigeria and Ghana
2016-08-17	BioGaia AB, Interim Report 1 January – 30 June 2016

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. biogaia.com